GETZ PHARMA PAKISTAN (PVT) LTD

Orlifit Capsules 120mg

Orlifit Capsules 120mg

Regular price Rs.800.00
Regular price Sale price Rs.800.00
Sale Sold out
Shipping calculated at checkout.

Product Overview

  • Product Form: Capsule
  • Pack Size: 120mg
  • Manufactured By: GETZ PHARMA PAKISTAN (PVT) LTD
  • Prescription Required: Yes

Product Details

Orlifit Capsules 120mg is a weight management solution containing Orlistat, an effective ingredient that aids in weight loss by blocking the absorption of dietary fat in the intestines. By inhibiting lipase, an enzyme responsible for breaking down fats, Orlifit helps reduce the amount of fat that your body absorbs from your diet, promoting weight loss and aiding in weight management.

Purposes

The primary purpose of Orlifit Capsules is to support weight loss. It is used as part of a comprehensive weight management program that includes a reduced-calorie diet and regular exercise. Orlifit is particularly beneficial for individuals struggling with obesity, helping them achieve and maintain a healthier weight by reducing fat absorption.

Warnings

Orlifit Capsules should be used with caution in patients taking anticonvulsant medications, as Orlistat may decrease the absorption of antiepileptic drugs and potentially lead to convulsions. Patients must adhere strictly to dietary recommendations to avoid gastrointestinal issues and potential imbalances in medication. Persistent or severe rectal bleeding should be investigated further by a healthcare provider.

Adverse Effects

Common side effects of Orlifit Capsules include gastrointestinal issues such as fecal incontinence, oily stools, and abdominal discomfort. Other reported side effects are respiratory infections, headaches, menstrual irregularities, and fatigue. Rare but serious effects may include elevated liver enzymes, hepatitis, and rectal bleeding. Monitoring for these symptoms is essential while using Orlifit.

Cautions

Patients with type II diabetes may experience less weight loss with Orlifit compared to non-diabetic individuals and may need close monitoring of their anti-diabetic treatment. Additionally, Orlifit Capsules should not be used by individuals with hypersensitivity to Orlistat, chronic malabsorption syndrome, cholestasis, or during breastfeeding. Always consult with a healthcare provider before starting Orlifit to ensure it is appropriate for your condition and to manage any potential interactions with other medications.

View full details

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)